Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 3,156 | 2,823 | 3,708 | 2,120 | 2,068 |
| Operating Income | -3,156 | -2,823 | -3,708 | -2,120 | -2,068 |
| Other Income | 69 | 122 | -641 | 2,737 | 2,581 |
| Pre-tax Income | -3,087 | -2,701 | -4,349 | 617 | 513 |
| Net Income Continuous | -3,087 | -2,701 | -4,349 | 617 | 513 |
| Minority Interests | -11 | -9 | -9 | -23 | -13 |
| Net Income | $-3,076 | $-2,692 | $-4,340 | $640 | $526 |
| EPS Basic Total Ops | -1.92 | -6.43 | -15.40 | 61.77 | 4.86 |
| EPS Basic Continuous Ops | -1.93 | -2.42 | -7.74 | 62.52 | 4.75 |
| EPS Diluted Total Ops | -1.92 | -6.43 | -15.40 | 61.77 | 4.86 |
| EPS Diluted Continuous Ops | -1.93 | -2.42 | -7.74 | 62.52 | 4.75 |
| EPS Diluted Before Non-Recurring Items | N/A | -6.43 | -15.40 | 42.11 | 4.51 |
| EBITDA(a) | $-3,156 | $-2,823 | $-3,708 | $-2,120 | $-2,068 |